Does Rallies show 13F holders for IVVD?

Yes. Rallies tracks hedge fund and 13F ownership data for IVVD, including fund names, share counts, latest tracked quarter, and position changes when available.

Is IVVD research on Rallies investment advice?

No. Rallies provides research, data, and educational context for IVVD. It does not provide personalized investment advice.

IVVD (Invivyd, Inc. Common Stock) Stock Analysis - Hedge Fund Holdings

Invivyd, Inc. Common Stock (IVVD) is a publicly traded Healthcare sector company. As of May 21, 2026, IVVD trades at $1.13 with a market cap of $332.91M and a P/E ratio of -3.52. IVVD moved +4.33% today. Year to date, IVVD is -57.25%; over the trailing twelve months it is +34.70%. Its 52-week range spans $0.35 to $3.07. Analyst consensus is strong buy with an average price target of $10.00. Rallies surfaces IVVD's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns IVVD stock?

Hedge funds tracked by Rallies that own IVVD include Maverick Capital, Redmile Group, Orbimed Advisors, Duquesne Family, and A16Z Perennial. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Invivyd, Inc. Common Stock.

IVVD Key Metrics

Key financial metrics for IVVD
Metric	Value
Price	$1.13
Market Cap	$332.91M
P/E Ratio	-3.52
EPS	$-0.30
Dividend Yield	0.00%
52-Week High	$3.07
52-Week Low	$0.35
Volume	1.67K
Avg Volume	0
Revenue (TTM)	$53.43M
Net Income	$-52.49M
Gross Margin	0.00%

Top Hedge Funds Holding IVVD

Maverick Capital holds 18.97M shares of IVVD, changed +0.00% as of Mar 31, 2026.
Redmile Group holds 2.65M shares of IVVD, changed -1.21% as of Mar 31, 2026.
Orbimed Advisors holds 933.50K shares of IVVD, changed -18.78% as of Mar 31, 2025.
Duquesne Family holds 571.42K shares of IVVD, changed +0.00% as of Mar 31, 2025.
A16Z Perennial holds 79.87K shares of IVVD, changed +0.00% as of Mar 31, 2026.

Latest IVVD News

Invivyd’s Q1 Revenue Drops to $13.7M, 22% PEMGARDA Growth Fails to Offset EPS Miss — May 14, 2026
Invivyd Q1 PEMGARDA Revenue Climbs 22% to $13.7M with $204.2M Cash — May 14, 2026
Invivyd CSO Unveils mAb Platform Addressing Virus Variation and Scalability at Vaccine Congress — Mar 30, 2026
Invivyd Completes VYD2311 Trial Enrollment, PEMGARDA Sales Rise 31% — Mar 6, 2026
Invivyd Q4 Revenue Rises 25% to $17.2M; Cash Hits $226.7M — Mar 5, 2026

Recent IVVD Insider Trades

Allen Robert D. III sold 19.39K (~$30.60K) on Feb 18, 2026.
Green Julie sold 20.96K (~$33.08K) on Feb 18, 2026.
Duke William E. sold 20.96K (~$33.08K) on Feb 18, 2026.

IVVD Analyst Consensus

3 analysts cover IVVD: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $10.00.

Common questions about IVVD

Who owns IVVD stock?: Hedge funds tracked by Rallies that own IVVD include Maverick Capital, Redmile Group, Orbimed Advisors, Duquesne Family, and A16Z Perennial. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Invivyd, Inc. Common Stock.
Does Rallies show 13F holders for IVVD?: Yes. Rallies tracks hedge fund and 13F ownership data for IVVD, including fund names, share counts, latest tracked quarter, and position changes when available.
Is IVVD research on Rallies investment advice?: No. Rallies provides research, data, and educational context for IVVD. It does not provide personalized investment advice.